Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Progression to AML Is Predictable and Distinct from Age Related Clonal Hematopoiesis

Sagi Abelson, PhD, Stanley W.K. Ng, Omer Wiessbrod, Philip Zuzarte, Lawrence Heisler, Yogi Sundaravadanam, Ting Ting Wang, Trevor J. Pugh, PhD, David Soave, Paul Brennan, Mattias Johansson, Phillip Awadalla, Scott V. Bratman, Jean Wang, MD PhD, Mark D. Minden, MD PhD, John E. Dick, PhD, Liran I. Shlush

Blood (2017) 130 (Supplement 1): 471.

https://doi.org/10.1182/blood.V130.Suppl_1.471.471

Published: 2017

Journal Articles

Functional Geriatric Assessment (F-GA) in Multiple Myeloma Patients: Results from a Prospective Multicenter Study Group (DSMM) Trial and Changes from Baseline to Follow-up Assessment

Sophia Scheubeck, Sandra Maria Dold, M. Sc., Gabriele Ihorst, PhD, Alexander Zober, MD, Stefan J. Müller, Dipl.-Pharm., Christian Langer, MD, Wolfram Pönisch, Lars-Olof Mügge, MD, Stefan Knop, MD, Justus Duyster, MD, Martin Schumacher, PhD, Ralph M. Waesch, MD, Monika Engelhardt, MD

Blood (2016) 128 (22): 5627.

https://doi.org/10.1182/blood.V128.22.5627.5627

Published: 2016

Journal Articles

Computational Analysis of Genomic Abnormalities from a Phase 3 Trial of Rigosertib in Higher-Risk MDS: Simulation of a Predictive Signature for Clinical Response

Guillermo Garcia-Manero, MD, Michael E. Petrone, MD MPH, Steven M. Fruchtman, MD, Bernard Brownstein, MD, Hannes Loferer, PhD, Nozar Azarnia, PhD, Shireen Vali, PhD, Neeraj Kumar Singh, Shahabuddin Usmani, Himanshu Grover, Taher Abbasi, Lewis R. Silverman, MD

Blood (2016) 128 (22): 4324.

https://doi.org/10.1182/blood.V128.22.4324.4324

Published: 2016

Journal Articles

A Genomic Predictive Signature for Rigosertib in Lower Risk MDS Derived By Integrating Clinical Response, Mechanism of Action Data and Simulation

Steven M. Fruchtman, MD, Abdullah Mahmood Ali, PhD, Michael E. Petrone, MD MPH, Patrick Simon Zbyszewski, MBA, Benjamin Hoffman, PhD, Shireen Vali, PhD, Neeraj Kumar Singh, Shahabuddin Usmani, Himanshu Grover, Taher Abbasi, Azra Raza, MD

Blood (2016) 128 (22): 5535.

https://doi.org/10.1182/blood.V128.22.5535.5535

Published: 2016

Journal Articles

Comparison of Two Rapid Predictive Methods for Therapeutic Targeting in Acute Myeloid Leukaemia Cells

Martin Grundy, PhD, Jones Thomas, BSc, Liban Elmi, B MDSci, Michael Hall, B MDSci, Nigel H Russell, MD, Monica Pallis, PhD

Blood (2016) 128 (22): 1704.

https://doi.org/10.1182/blood.V128.22.1704.1704

Published: 2016

Journal Articles

BCR Responsiveness is Associated with Time to First Treatment (TTFT) in B-Cell Chronic Lymphocytic Leukemia (B-CLL): Results From a Single Cell Network Profiling (SCNP) Verification Study

Alessandra Cesano, M.D., Ph.D., Erik Evensen, Ph.D., Jason Ptacek, PhD, James Cordeiro, Rachael E. Hawtin, Ph.D., Jodi R. Ware, PharmD, Ilaria Nichele, Maria Teresa Scupoli, Ph.D.

Blood (2011) 118 (21): 2834.

https://doi.org/10.1182/blood.V118.21.2834.2834

Published: 2011

Journal Articles

Single Cell Network Profiling (SCNP) Signatures Predict Response to Induction Therapy and Relapse Risk In Pediatric Patients with Acute Myeloid Leukemia: Children's Oncology Group (COG) Study POG-9421

Norman J. Lacayo, MD, Aileen Cohen, Ph.D., M.D., Matt Westfall, Ph.D., Alan Lackey, MS, Xiaohua (Robert) Xin, Ph.D., M.D., Urte Gayko, Ph.D., Santosh Putta, Ph.D., Soheil Meshinchi, MD, PhD, Susana C. Raimondi, PhD, Todd A. Alonzo, PhD, Robert J. Arceci, MD, PhD, Yaddanapudi Ravindranath, MD, Gary Van Houten Dahl, MD, Alessandra Cesano, MD

Blood (2010) 116 (21): 954.

https://doi.org/10.1182/blood.V116.21.954.954

Published: 2010

Journal Articles

Definition of a Diagnostic Window Prior to the Onset of Clinically Apparent Acute Graft-Versus-Host Disease.

Carina A Bäuerlein, Simone S Riedel, Brede Christian, Ana-Laura Jordán Garrote, Agnes Birner, Carolin Kiesel, Miriam Ritz, Stephan Schulz, Marina Grether, Georg F Beilhack, Robert Negrin, MD, Hermann Einsele, MD, Andreas Beilhack

Blood (2010) 116 (21): 3746.

https://doi.org/10.1182/blood.V116.21.3746.3746

Published: 2010

Journal Articles

Single-Cell Network Profiliing (SCNP) Signatures Independently Predict Response to Induction Therapy In Older Patients with Acute Myeloid Leukemia (AML)

Alessandra Cesano, MD, Santosh Putta, Ph.D., Urte Gayko, Ph.D., James Hackett, Ph.D., David B. Rosen, PhD, Larry Cripe, MD, Zhuoxin Sun, PhD, Hajime Uno, PhD, Mark R. Litzow, MD, Martin S. Tallman, MD, Elisabeth Paietta, PhD

Blood (2010) 116 (21): 2695.

https://doi.org/10.1182/blood.V116.21.2695.2695

Published: 2010

Journal Articles

Impact of TET2 mutations On Responsiveness to Demethylating Agents in MDS.

Anna M. Jankowska, MSc, Mohammed Shaik, MD, Heather Cazzolli, Rebecca Ganetzky, B.A, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 1606.

https://doi.org/10.1182/blood.V114.22.1606.1606

Published: 2009

Journal Articles

Single Cell Network Profiles in Non-M3 AML Associated with Patient Response to Standard Induction Therapy.

Steven Kornblau, M.D., M. D. Minden, MD, PhD, David B. Rosen, PhD, Santosh Putta, PhD, Aileen C. Cohen, MD, PhD, Todd Covey, Wendy J. Fantl, PhD, Urte Gayko, PhD, Alessandra Cesano, MD, PhD

Blood (2009) 114 (22): 1582.

https://doi.org/10.1182/blood.V114.22.1582.1582

Published: 2009

Journal Articles

A Functional Assay for Peripheral Blood T Cells to Predict Acute Graft-Versus-Host Disease.

Carina A Baeuerlein, Christian Brede, Simone S Riedel, Ana-Laura Jordán-Garrote, Carolin Kiesel, Miriam Ritz, Stephan Schulz, MD, Marina Grether, Georg F Beilhack, MD, Tor B Stuge, PhD, Robert S Negrin, MD, Hermann Einsele, MD, Andreas Beilhack, MD

Blood (2009) 114 (22): 4497.

https://doi.org/10.1182/blood.V114.22.4497.4497

Published: 2009

Journal Articles

Immune Reconstitution and Immune Correlates of Clinical Outcome IN Acute LEUKEMIA PATIENTS Treated with Haploidentical STEM CELL TRANSPLANTATION.

Alessandra Forcina, Maddalena Noviello, Veronica Valtolina, Attilio Bondanza, Daniela Clerici, Luca Vago, Sara Mastaglio, Maria Teresa Lupo-Stanghellini, Katharina Fleischhauer, Consuelo Corti, Massimo Bernardi, Jacopo Peccatori, Claudio Bordignon, Fabio Ciceri, Chiara Bonini

Blood (2009) 114 (22): 46.

https://doi.org/10.1182/blood.V114.22.46.46

Published: 2009

Journal Articles

Genetic Variation in ADME Genes Is Associated with Thalidomide Related Peripheral Neuropathy in Multiple Myeloma Patients.

David C Johnson, Christine Ramos, Alex J. Szubert, Walter M Gregory, J. Anthony Child, Faith E Davies, MD, Brian GM Durie, MD, Brian G. Van Ness, PhD, Gareth J Morgan, MD, PhD

Blood (2008) 112 (11): 1675.

https://doi.org/10.1182/blood.V112.11.1675.1675

Published: 2008

Journal Articles

Multiplex Assay for Profiling Plasma Protein Biomarkers for Improved Diagnosis and Prognosis of Heparin Induced Thrombocytopenia (HIT).

Resmi Ravindran, PhD, Imran Khan, PhD, Robert C. Gosselin, Ted Wun, MD, Krish Krishnan, PhD, Paul Luciw, PhD, Kim A. Janatpour, MD

Blood (2006) 108 (11): 4106.

https://doi.org/10.1182/blood.V108.11.4106.4106

Published: 2006

Journal Articles

A Prospective Risk Model for Neutropenic Complications in Patients with Malignant Lymphoma.

Gary H. Lyman, MD, MPH, Jeffrey Crawford, MD, Debra Wolff, MS, PCNP, Eva Culakova, PhD, Marek S. Poniewierski, MD, MS, David C. Dale, MD

Blood (2005) 106 (11): 3328.

https://doi.org/10.1182/blood.V106.11.3328.3328

Published: 2005

Journal Articles

A Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

Gary H. Lyman, MD, MPH, Brandon McMahon, MD, Nicole M. Kuderer, MD, Jeffrey Crawford, MD, Debra Wolff, MS, PCNP, Eva Culakova, PhD, Marek S. Poniewierski, MD, MS, David C. Dale, MD

Blood (2005) 106 (11): 754.

https://doi.org/10.1182/blood.V106.11.754.754

Published: 2005

Journal Articles

In Imatinib Treated CML Patients with Low Baseline IC50, Early Molecular Response Is Highly Predictive of Longer Term Molecular Outcome. In Patients with High IC50, Other Prognostic Indicators Are Needed.

Deborah L. White, Susan Branford, Verity A. Saunders, Kevin Lynch, Andrew Grigg, L. Bik To, Timothy P. Hughes

Blood (2005) 106 (11): 3283.

https://doi.org/10.1182/blood.V106.11.3283.3283

Published: 2005

NARROW

Progression to AML Is Predictable and Distinct from Age Related Clonal Hematopoiesis

Functional Geriatric Assessment (F-GA) in Multiple Myeloma Patients: Results from a Prospective Multicenter Study Group (DSMM) Trial and Changes from Baseline to Follow-up Assessment

Computational Analysis of Genomic Abnormalities from a Phase 3 Trial of Rigosertib in Higher-Risk MDS: Simulation of a Predictive Signature for Clinical Response

A Genomic Predictive Signature for Rigosertib in Lower Risk MDS Derived By Integrating Clinical Response, Mechanism of Action Data and Simulation

Comparison of Two Rapid Predictive Methods for Therapeutic Targeting in Acute Myeloid Leukaemia Cells

BCR Responsiveness is Associated with Time to First Treatment (TTFT) in B-Cell Chronic Lymphocytic Leukemia (B-CLL): Results From a Single Cell Network Profiling (SCNP) Verification Study

Single Cell Network Profiling (SCNP) Signatures Predict Response to Induction Therapy and Relapse Risk In Pediatric Patients with Acute Myeloid Leukemia: Children's Oncology Group (COG) Study POG-9421

Definition of a Diagnostic Window Prior to the Onset of Clinically Apparent Acute Graft-Versus-Host Disease.

Single-Cell Network Profiliing (SCNP) Signatures Independently Predict Response to Induction Therapy In Older Patients with Acute Myeloid Leukemia (AML)

Impact of TET2 mutations On Responsiveness to Demethylating Agents in MDS.

Single Cell Network Profiles in Non-M3 AML Associated with Patient Response to Standard Induction Therapy.

A Functional Assay for Peripheral Blood T Cells to Predict Acute Graft-Versus-Host Disease.

Immune Reconstitution and Immune Correlates of Clinical Outcome IN Acute LEUKEMIA PATIENTS Treated with Haploidentical STEM CELL TRANSPLANTATION.

Genetic Variation in ADME Genes Is Associated with Thalidomide Related Peripheral Neuropathy in Multiple Myeloma Patients.

Multiplex Assay for Profiling Plasma Protein Biomarkers for Improved Diagnosis and Prognosis of Heparin Induced Thrombocytopenia (HIT).

A Prospective Risk Model for Neutropenic Complications in Patients with Malignant Lymphoma.

A Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

In Imatinib Treated CML Patients with Low Baseline IC50, Early Molecular Response Is Highly Predictive of Longer Term Molecular Outcome. In Patients with High IC50, Other Prognostic Indicators Are Needed.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only